Breckenridge Pharmaceutical, Inc. — FDA Class II (D-0582-2026)

Breckenridge Pharmaceutical, Inc. is recalling 14,729 bottles of a human prescription drug due to a safety issue. The recall is classified as a Class II action, indicating a temporary health risk. The affected products have NDC numbers 51991-746, 51991-747, 51991-748, and 51991-750.

• •Breckenridge Pharmaceutical, Inc. is recalling 14,729 bottles of a drug.
• •The recall is due to a safety issue.
• •Affected products have NDC numbers 51991-746, 51991-747, 51991-748, and 51991-750.
• •This is classified as a Class II recall, indicating a moderate health risk.

Consumers who possess the recalled products should stop using them immediately. The recall affects 14,729 bottles, posing potential health risks.